Menu UF Health Home Menu

Content Tagged Michael Haller Subscribe to RSS Feed


Mobilization without immune depletion fails to restore immunological tolerance or preserve beta cell function in recent onset type 1 diabetes

Published: Oct 18th, 2015

UFDI investigators and collaborators found that granulocyte colony stimulating factor monotherapy did not affect C-peptide production, HbA1c, or insulin dose.This study supports the continued exploration of G-CSF and other mobilizing […]


Live interview with UFDI Investigator Michael Haller, M.D. via TrialNet

Published: Sep 28th, 2015

Dr. Haller currently serves as the Principal Investigator for the TrialNet ATG/GCSF study funded collaboratively by the NIH, the Helmsley Trust, and Sanofi.


UF type 1 diabetes research review highlights screening and study opportunities

Published: Sep 25th, 2015

Giovanna Beauchamp, M.D. and Michael J. Haller, M.D., M.S. recently released a review of several type 1 diabetes (T1D) prevention studies in Current Diabetes Reports. The publication, titled ‘Can We […]


Screening for T1D risk to reduce DKA is not economically viable

Published: Sep 25th, 2015

Several studies have documented reduced incidence of diabetic ketoacidosis (DKA) in new-onset T1D when high-risk children are identified at an early age. As a result, researchers have questioned whether T1D […]


New Onset T1D Study: Pancreatic Volume in Preclinical Type 1 Diabetes

Published: Sep 24th, 2015

UF researchers are seeking to determine differences in pancreatic volume between new-onset Type 1 Diabetes (T1D) patients, antibody positive subjects at increased risk for T1D, and healthy controls. The study […]


UF researchers release publication on the influence of type 1 diabetes on pancreatic weight

Published: Sep 13th, 2015

UFDI faculty and a University of Miami researcher found that “reduced pancreas weight allows for comparisons across a wide range of donor ages by eliminating confounding variables.”


Combination therapy for diabetes

Published: Feb 18th, 2015

Results from a UF Health pilot study have led to a new national trial investigating a combination treatment for individuals newly diagnosed with Type 1 diabetes.


Celiac screening for kids with type 1 diabetes

Published: Jul 11th, 2014

Several studies to date have found that people with type 1 diabetes (T1D) tend to have celiac disease more often than individuals in the general population. Michael Haller, MD, a pediatric endocrinologist at UF Health, told Medscape Medical News in a recent interview that screening every type 1 diabetes patient for the disease presents a unique clinical challenge.


UF Researchers Present at ADA’s 74th Scientific Sessions

Published: Jun 21st, 2014

UF and UF Health faculty, postdoctoral fellows, and graduate students submitted a record number of original research presentations for the American Diabetes Association’s 74th Scientific Sessions held June 13-17, 2014 at the Moscone Center in San Francisco, California. This year’s submissions represent one of the largest showcases of research emanating from UF.


Treatment could spur production of insulin in Type 1 diabetes

Published: Jun 17th, 2014

Combining two different medications could help patients with Type 1 diabetes at least partially regain the ability to produce their own insulin, according to UF Health pediatric endocrinologist Michael Haller, MD.